nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Author index
|
|
|
2012 |
48 |
S2 |
p. S17- 1 p. |
artikel |
2 |
10 Capecitabine based adjuvant therapy for stage III colon cancer — single institution experience
|
Mitreski, N. |
|
2012 |
48 |
S2 |
p. S15- 1 p. |
artikel |
3 |
08 Colorectal cancer in elderly patients: A single-center experience
|
Bensalem, A. |
|
2012 |
48 |
S2 |
p. S15- 1 p. |
artikel |
4 |
Editorial Board
|
|
|
2012 |
48 |
S2 |
p. ii- 1 p. |
artikel |
5 |
04 Effect of one year adjuvant imatinib on gastric stromal tumors
|
Bensalem, A. |
|
2012 |
48 |
S2 |
p. S14- 1 p. |
artikel |
6 |
03 Extracapsular lymph node spread: not-so-well known but important prognostic factor in gastric cancer
|
Picchetto, A. |
|
2012 |
48 |
S2 |
p. S13-S14 2 p. |
artikel |
7 |
14 Long term results after multimodal treatment for advanced oral squamous cell carcinoma
|
Poeschl, P.W. |
|
2012 |
48 |
S2 |
p. S16- 1 p. |
artikel |
8 |
05 Methylation of MLH1, MGMT, DAPK genes in the cancerous and adjacent non-cancerous stomach tissues
|
Kupcinskaite-Noreikiene, R. |
|
2012 |
48 |
S2 |
p. S14- 1 p. |
artikel |
9 |
02 miRNA network dysregulation in hepatocarcinogenesis
|
Halytskiy, V.A. |
|
2012 |
48 |
S2 |
p. S13- 1 p. |
artikel |
10 |
13 Palliative care in gastrointestinal malignancies patients at a regional cancer centre in India
|
Mishra, S. |
|
2012 |
48 |
S2 |
p. S16- 1 p. |
artikel |
11 |
12 Pattern of local recurrence and treatment following surgery with total mesorectal excision (TME) for rectal cancer
|
Chiappa, A. |
|
2012 |
48 |
S2 |
p. S16- 1 p. |
artikel |
12 |
PG 5.02 Adenocarcinoma of the GEJ: gastric or oesophageal cancer?
|
Rüschoff, J. |
|
2012 |
48 |
S2 |
p. S5- 1 p. |
artikel |
13 |
PG 10.04 Adjuvant chemotherapy: an option for Asian patients only?
|
Bang, Y.-J. |
|
2012 |
48 |
S2 |
p. S11- 1 p. |
artikel |
14 |
PG 4.03 Adjuvant therapy in resected pancreatic cancer
|
Neoptolemos, J.P. |
|
2012 |
48 |
S2 |
p. S4- 1 p. |
artikel |
15 |
PG 6.04 Biomarkers in the management of oesophageal cancer
|
Ajani, J. |
|
2012 |
48 |
S2 |
p. S7- 1 p. |
artikel |
16 |
PG 9.03 Can adjuvant radiochemothrapy replace extended lymph node dissection?
|
Jansen, E.P.M. |
|
2012 |
48 |
S2 |
p. S9-S10 2 p. |
artikel |
17 |
PG 3.01 Cancer stem cells: the new target
|
Fodde, R. |
|
2012 |
48 |
S2 |
p. S3- 1 p. |
artikel |
18 |
PG 1.02 Clinically relevant study end points in rectal cancer
|
Fernandez-Martos, C. |
|
2012 |
48 |
S2 |
p. S1- 1 p. |
artikel |
19 |
PG 2.02 Colorectal cancer with synchronous liver metastases
|
Ruers, T. |
|
2012 |
48 |
S2 |
p. S2- 1 p. |
artikel |
20 |
PG 6.03 Criteria for selecting the best multimodial therapy
|
Hölscher, A.H. |
|
2012 |
48 |
S2 |
p. S6-S7 2 p. |
artikel |
21 |
PG 2.01 Differentiating colon cancer by clinical criteria
|
Van Cutsem, E. |
|
2012 |
48 |
S2 |
p. S2- 1 p. |
artikel |
22 |
PG 1.04 How to select the appropriate surgical approach in rectal cancer
|
Holm, T. |
|
2012 |
48 |
S2 |
p. S2- 1 p. |
artikel |
23 |
PG 9.02 Is endosonography and laparoscopy essential before neoadjuvant therapy?
|
Schuhmacher, C. |
|
2012 |
48 |
S2 |
p. S9- 1 p. |
artikel |
24 |
PG 2.03 Lessons from PETACC3 in adjuvant treatment of colorectal cancer: today's impact
|
Roth, A. |
|
2012 |
48 |
S2 |
p. S3- 1 p. |
artikel |
25 |
PG 10.03 Lessons from the GASTRIC metaanalysis of adjuvant treatment
|
Rougier, P. |
|
2012 |
48 |
S2 |
p. S10-S11 2 p. |
artikel |
26 |
PG 5.01 Modern endoscopic imaging of gastrooesophageal lesions: Different techniques for different locations
|
Kiesslich, R. |
|
2012 |
48 |
S2 |
p. S5- 1 p. |
artikel |
27 |
PG 5.03 Molecular mechanisms in gastric cancer: Basis for therapy?
|
Seruca, R. |
|
2012 |
48 |
S2 |
p. S5- 1 p. |
artikel |
28 |
PG 4.01 Neoadjuvant approaches to pancreatic cancer
|
Lesurtel, M. |
|
2012 |
48 |
S2 |
p. S3- 1 p. |
artikel |
29 |
PG 1.03 Neoadjuvant treatment: Do we need radiotherapy?
|
Glynne-Jones, R. |
|
2012 |
48 |
S2 |
p. S1-S2 2 p. |
artikel |
30 |
PG 9.04 Oesophagogastric cancer: A case for perioperative chemotherapy
|
Ychou, M. |
|
2012 |
48 |
S2 |
p. S10- 1 p. |
artikel |
31 |
PG 6.02 Open or microinvasive resection?
|
Mariette, C. |
|
2012 |
48 |
S2 |
p. S6- 1 p. |
artikel |
32 |
PG 9.01 Optimal surgery for gastric cancer: Is more always better?
|
Allum, W. |
|
2012 |
48 |
S2 |
p. S9- 1 p. |
artikel |
33 |
PG 7.03 Optimizing neoadjuvant chemotherapy through the use of early response evaluation (PET)
|
Lordick, F. |
|
2012 |
48 |
S2 |
p. S8- 1 p. |
artikel |
34 |
PG 4.02 Pancreatic surgery: Beyond the traditional limits
|
Schmied, B. |
|
2012 |
48 |
S2 |
p. S3-S4 2 p. |
artikel |
35 |
PG 10.02 Predicting the response to neoadjuvant chemotherapy II (Ability of pretherapeutic parameters to predict response and prognosis early in patients with locally advanced gastric cancer)
|
Lorenzen, S. |
|
2012 |
48 |
S2 |
p. S10- 1 p. |
artikel |
36 |
PG 10.01 Predicting the response to neoadjuvant chemotherapy I (Who profits from neoadjuvant chemotherapy)
|
Mariette, C. |
|
2012 |
48 |
S2 |
p. S10- 1 p. |
artikel |
37 |
PG 4.04 Radiochemotherapy of the pancreas: State of the art 2012
|
Mornex, F. |
|
2012 |
48 |
S2 |
p. S4-S5 2 p. |
artikel |
38 |
PG 1.01 Rectal cancer: what is the aim of multimodal therapy?
|
Arnold, D. |
|
2012 |
48 |
S2 |
p. S1- 1 p. |
artikel |
39 |
PG 10.05 Selecting the best treatment for an individual patient
|
Cascinu, S. |
|
2012 |
48 |
S2 |
p. S11- 1 p. |
artikel |
40 |
PG 2.04 Systemic treatment of CRC: Molecular profiles ready for clinical practice?
|
Tejpar, S. |
|
2012 |
48 |
S2 |
p. S3- 1 p. |
artikel |
41 |
PG 7.01 When is definite radiochemotherapy the treatment of choice?
|
Stahl, M. |
|
2012 |
48 |
S2 |
p. S7- 1 p. |
artikel |
42 |
PG 7.04 When is neoadjuvant radiochemotherapy the treatment of choice?
|
Van der Gaast, A. |
|
2012 |
48 |
S2 |
p. S8- 1 p. |
artikel |
43 |
PG 6.01 Who is a candidate for endoscopic surgery?
|
Oyama, T. |
|
2012 |
48 |
S2 |
p. S5-S6 2 p. |
artikel |
44 |
PG 5.04 Why is there a change in patterns of GE cancer?
|
Jankowski, J. |
|
2012 |
48 |
S2 |
p. S5- 1 p. |
artikel |
45 |
PG 8.01 Writing and submitting an outstanding scientific manuscript
|
Haller, D.G. |
|
2012 |
48 |
S2 |
p. S8-S9 2 p. |
artikel |
46 |
06 Postoperative chemotherapy and disease-free survival in esophageal and gastric adenocarcinoma
|
Alcindor, T. |
|
2012 |
48 |
S2 |
p. S14- 1 p. |
artikel |
47 |
07 Serum tryptase as a new biomarker in colorectal cancer patients
|
Ammendola, M. |
|
2012 |
48 |
S2 |
p. S14-S15 2 p. |
artikel |
48 |
09 The intra-tumor stroma microenvironment as a strong prognosticator for colon cancer
|
Mesker, W. |
|
2012 |
48 |
S2 |
p. S15- 1 p. |
artikel |
49 |
01 The risk level of liver cancer cases among smokers in developing countries
|
Odiase, E.O. |
|
2012 |
48 |
S2 |
p. S13- 1 p. |
artikel |
50 |
11 Use of IHC and DISH of EGFR to evaluate efficacy of anti-EGFR drugs in KRAS-WT patients with mCRC
|
Takahashi, N. |
|
2012 |
48 |
S2 |
p. S15-S16 2 p. |
artikel |